Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vardenafil Daily vs PRN vs Placebo for Erectile Function Recovery After Prostatectomy
NCT00492635Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2004
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 15
01
Overview
Phase 3, randomised, double-blind trial of vardenafil in erectile dysfunction (ED) (3 arms), sponsored by Bayer. Primary endpoint: Recovery of erectile function at 9 months. Started Dec 2004; status: completed.
02
Drugs
vardenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00492635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00492635.